Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner

• Κύριοι συγγραφείς: Miao Zeng (Συγγραφέας), Wei Zhang (Συγγραφέας), Yisheng Li (Συγγραφέας), Li Yu (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: BMC, 2024-03-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Recombinant adenovirus (rAd) regimens, including replication-competent oncolytic adenovirus (OAV) and replication-deficient adenovirus, have been identified as potential cancer therapeutics. OAV presents advantages such as selective replication, oncolytic efficacy, and tumor microenvironmen...